Haleon PLC (HLN)
8.33
+0.09
(+1.09%)
USD |
NYSE |
May 07, 16:00
8.33
0.00 (0.00%)
After-Hours: 20:00
Haleon Total Return Level: 8.454 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 8.454 |
May 03, 2024 | 8.515 |
May 02, 2024 | 8.536 |
May 01, 2024 | 8.566 |
April 30, 2024 | 8.751 |
April 29, 2024 | 8.690 |
April 26, 2024 | 8.669 |
April 25, 2024 | 8.618 |
April 24, 2024 | 8.566 |
April 23, 2024 | 8.628 |
April 22, 2024 | 8.577 |
April 19, 2024 | 8.433 |
April 18, 2024 | 8.341 |
April 17, 2024 | 8.320 |
April 16, 2024 | 8.310 |
April 15, 2024 | 8.269 |
April 12, 2024 | 8.218 |
April 11, 2024 | 8.382 |
April 10, 2024 | 8.382 |
April 09, 2024 | 8.505 |
April 08, 2024 | 8.433 |
April 05, 2024 | 8.505 |
April 04, 2024 | 8.443 |
April 03, 2024 | 8.454 |
April 02, 2024 | 8.495 |
Date | Value |
---|---|
April 01, 2024 | 8.556 |
March 28, 2024 | 8.71 |
March 27, 2024 | 8.751 |
March 26, 2024 | 8.628 |
March 25, 2024 | 8.648 |
March 22, 2024 | 8.597 |
March 21, 2024 | 8.546 |
March 20, 2024 | 8.454 |
March 19, 2024 | 8.597 |
March 18, 2024 | 8.330 |
March 15, 2024 | 8.525 |
March 14, 2024 | 8.443 |
March 13, 2024 | 8.700 |
March 12, 2024 | 8.771 |
March 11, 2024 | 8.670 |
March 08, 2024 | 8.741 |
March 07, 2024 | 8.660 |
March 06, 2024 | 8.437 |
March 05, 2024 | 8.437 |
March 04, 2024 | 8.417 |
March 01, 2024 | 8.558 |
February 29, 2024 | 8.670 |
February 28, 2024 | 8.163 |
February 27, 2024 | 8.346 |
February 26, 2024 | 8.376 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
5.63
Minimum
Sep 02 2022
9.065
Maximum
Apr 20 2023
7.929
Average
8.252
Median
Total Return Level Benchmarks
Pfizer Inc | 96.24 |
GSK PLC | 284.88 |
AstraZeneca PLC | 216.99 |
Verona Pharma PLC | 14.95 |
Adaptimmune Therapeutics PLC | 1.13 |